Success measured in lives saved
Over 90,000 patients and counting have been successfully treated with EKOS.
“Despite many options for interventional treatment for PE, EKOS remains the most applicable, straightforward and data driven available. The OPTALYSE protocol has greatly simplified the approach with a limited dose of tPA and short infusion time. This patient, as with others, exemplified these EKOS features leading to accelerated symptom improvement with very low complications and, therefore, continues to bring us back to EKOS as our go-to therapy for the interventional treatment of PE.“
— Anas Safadi, MD, ABVM, FACC, FSCAI
“I continue to use EKOS because of the efficacy, results, and patient outcomes I have gotten. When treating these patients, I take into consideration a lot of factors and EKOS checks a lot of boxes: Ease of use, safety and small profile, and successful patient outcomes."
— Amit Dwivedi, MD
